The value of survival gains from therapeutic innovations for US patients with relapsed/refractory multiple myeloma

by Joanna P MacEwan, Istvan Majer, Jacquelyn W Chou, Sumeet Panjabi
Published 2021-07-01

Non–Small Cell Lung Cancer Patient Preferences for First-Line Treatment: A Discrete Choice Experiment

by Joanna P. MacEwan, Komal Gupte-Singh, Lauren M. Zhao, Karen L. Reckamp
Published 2020-05-01

The Value of Progression-Free Survival in Metastatic Breast Cancer: Results From a Survey of Patients and Providers

by Joanna P. MacEwan, Jason Doctor, Karen Mulligan, Suepattra G. May, Katharine Batt, Christopher Zacker, Darius Lakdawalla, Dana Goldman
Published 2019-06-01